Intuitive Surgical, Inc. $ISRG Stock: SFE Investment Counsel Grows Position

SFE Investment Counsel increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,957 shares of the medical equipment provider’s stock after acquiring an additional 2,548 shares during the quarter. SFE Investment Counsel’s holdings in Intuitive Surgical were worth $2,016,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Stevens Capital Partners lifted its holdings in shares of Intuitive Surgical by 9.9% during the third quarter. Stevens Capital Partners now owns 686 shares of the medical equipment provider’s stock worth $279,000 after purchasing an additional 62 shares during the period. ProShare Advisors LLC grew its position in Intuitive Surgical by 3.4% in the 3rd quarter. ProShare Advisors LLC now owns 398,808 shares of the medical equipment provider’s stock valued at $162,167,000 after buying an additional 12,952 shares during the last quarter. Vise Technologies Inc. grew its position in Intuitive Surgical by 43.7% in the 3rd quarter. Vise Technologies Inc. now owns 20,025 shares of the medical equipment provider’s stock valued at $8,143,000 after buying an additional 6,087 shares during the last quarter. Investment Partners LTD. increased its stake in Intuitive Surgical by 105.9% in the 3rd quarter. Investment Partners LTD. now owns 2,854 shares of the medical equipment provider’s stock valued at $1,161,000 after buying an additional 1,468 shares during the period. Finally, Cidel Asset Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at $216,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $432.01 on Friday. The business’s fifty day moving average is $401.54 and its two-hundred day moving average is $434.05. The company has a market cap of $149.75 billion, a price-to-earnings ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.40 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy Ladd sold 400 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the director directly owned 251 shares of the company’s stock, valued at $95,129. This trade represents a 61.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the sale, the vice president directly owned 1,026 shares in the company, valued at approximately $464,993.46. The trade was a 79.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 38,778 shares of company stock worth $16,814,967. 0.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on ISRG shares. Mizuho lowered their target price on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a report on Wednesday, October 21st. Evercore set a $430.00 price target on shares of Intuitive Surgical in a report on Monday, July 6th. Royal Bank Of Canada dropped their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 21st. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Finally, TD Cowen reissued a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a report on Monday, October 19th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.